These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9867111)

  • 1. Oxidative stress in the liver and biliary tract diseases.
    Fehér J; Lengyel G; Blázovics A
    Scand J Gastroenterol Suppl; 1998; 228():38-46. PubMed ID: 9867111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of free radicals, oxidative stress and antioxidant systems in liver diseases].
    Jakus V; Lopuchova M
    Bratisl Lek Listy; 1999; 100(10):548-59. PubMed ID: 10649852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
    Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cell protection in toxic liver lesion.
    Fehér J; Cornides A; Pál J; Láng I; Csomós G
    Acta Physiol Hung; 1989; 73(2-3):285-91. PubMed ID: 2596318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radicals in tissue damage in liver diseases and therapeutic approach.
    Fehér J; Láng I; Deák G; Cornides A; Nékám K; Gergely P
    Tokai J Exp Clin Med; 1986; 11 Suppl():121-34. PubMed ID: 3452238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Silymarin in the treatment of chronic liver diseases: past and future].
    Fehér J; Lengyel G
    Orv Hetil; 2008 Dec; 149(51):2413-8. PubMed ID: 19073452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients.
    Fehér J; Láng I; Nékám K; Gergely P; Mũzes G
    Tokai J Exp Clin Med; 1990 May; 15(2-3):129-34. PubMed ID: 2130521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silymarin: a review of its clinical properties in the management of hepatic disorders.
    Wellington K; Jarvis B
    BioDrugs; 2001; 15(7):465-89. PubMed ID: 11520257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective and immunological effects of antioxidant drugs.
    Láng I; Nékám K; González-Cabello R; Mũzes G; Gergely P; Fehér J
    Tokai J Exp Clin Med; 1990 May; 15(2-3):123-7. PubMed ID: 1983370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective and immunomodulatory effects of antioxidant therapy.
    Láng I; Deák G; Nékám K; Müzes G; González-Cabello R; Gergely P; Fehér J
    Acta Med Hung; 1988; 45(3-4):287-95. PubMed ID: 3074277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis.
    Fehér J; Láng I; Nékám K; Müzes G; Deák G
    Acta Med Hung; 1988; 45(3-4):265-76. PubMed ID: 3249654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antioxidants in liver protection].
    Hagymási K; Blázovics A
    Orv Hetil; 2004 Jul; 145(27):1421-5. PubMed ID: 15320484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme.
    Müzes G; Deák G; Láng I; Nékám K; Gergely P; Fehér J
    Acta Physiol Hung; 1991; 78(1):3-9. PubMed ID: 1763650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoprotective effect of kaempferol against alcoholic liver injury in mice.
    Wang M; Sun J; Jiang Z; Xie W; Zhang X
    Am J Chin Med; 2015; 43(2):241-54. PubMed ID: 25787296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Oxidative Stress and Antioxidants in Liver Diseases.
    Li S; Tan HY; Wang N; Zhang ZJ; Lao L; Wong CW; Feng Y
    Int J Mol Sci; 2015 Nov; 16(11):26087-124. PubMed ID: 26540040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoprotective and antioxidant activity of Phaseolus trilobus, Ait on bile duct ligation induced liver fibrosis in rats.
    Fursule RA; Patil SD
    J Ethnopharmacol; 2010 Jun; 129(3):416-9. PubMed ID: 20430092
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Li L; Zhou YF; Li YL; Wang LL; Arai H; Xu Y
    World J Gastroenterol; 2017 Apr; 23(16):2912-2927. PubMed ID: 28522909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.